Merck & Co (MRK) Earnings Date & Reports

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MRK is expected to report earnings to fall 7.21% to $2.06 per share on July 29

Q2'25

Est.

$2.06

Q1'25

Beat

by $0.08

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.12

The last earnings report on April 24 showed earnings per share of $2.22, beating the estimate of $2.14. With 15.61M shares outstanding, the current market capitalization sits at 331.75B.

View a ticker or compare two or three

Compare

MRK